MFDS — authorised 10 September 1998
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Arava in South Korea
MFDS authorised Arava on 10 September 1998
Marketing authorisation
Arava in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Arava approved in South Korea?
Yes. MFDS authorised it on 10 September 1998.
Who is the marketing authorisation holder for Arava in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.